Will Eliquis, Opdivo Fuel Bristol-Myers (BMY) Q3 Earnings?

11:55am, Monday, 24'th Oct 2022 Zacks Investment Research
Investors are likely to focus on the demand for Eliquis and Opdivo along with an incremental contribution from newer drugs when Bristol-Myers (BMY) reports Q3 results. Operating expenses might have ju

Merck (MRK) to Report Q3 Earnings: What's in the Cards?

11:47am, Monday, 24'th Oct 2022 Zacks Investment Research
Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, and COVID-19 antiviral pill, molnupiravir when the company reports Q3 earnings.

Assertio (ASRT) to Report Q3 Earnings: What's in the Cards?

09:21am, Monday, 24'th Oct 2022 Zacks Investment Research
Assertio Holdings' (ASRT) third-quarter performance is likely to reflect the sales performance of its marketed drugs and cost savings from the company's restructuring plans.

Universal Health (UHS) to Post Q3 Earnings: What's in Store?

05:17pm, Friday, 21'st Oct 2022 Zacks Investment Research
Universal Health's (UHS) Q3 results are likely to reflect sound segmental performances resulting from a constant pursuit of expansion moves. However, high labor costs might partly offset the results.

4 Biotech Stocks Set to Outpace Q3 Earnings Estimates

01:11pm, Friday, 21'st Oct 2022 Zacks Investment Research
Let us take a look at some biotech stocks, ARGX, BMRN, LLY and GMAB, which are poised to beat on third-quarter earnings.
Let us take a look at some biotech stocks, ARGX, BMRN, LLY and GMAB, which are poised to beat on third-quarter earnings.

What's in Store for Novartis (NVS) This Earnings Season?

04:26pm, Thursday, 20'th Oct 2022 Zacks Investment Research
Investors will focus on the regular top and bottom-line numbers along with updates on the Sandoz spin-off when Novartis (NVS) reports third-quarter 2022 results.

Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q3 Earnings Expected to Decline

02:02pm, Thursday, 20'th Oct 2022 Zacks Investment Research
Alnylam (ALNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cramer spoke with BioMarin Pharmaceutical CEO Jean-Jacques Bienaimé on Wednesday.

AVEO Pharmaceuticals (AVEO) Inks Deal to be Acquired by LG Chem

04:02pm, Wednesday, 19'th Oct 2022 Zacks Investment Research
Aveo Pharmaceuticals (AVEO) is set to be acquired by LG Chem for an aggregate amount of $566 billion. The deal is expected to close by early 2023. Stock up.

Akouos (AKUS) Surges on $610M Buyout Deal With Eli Lilly

03:42pm, Wednesday, 19'th Oct 2022 Zacks Investment Research
Akouos (AKUS) is set to be acquired by Eli Lilly for an aggregate amount of $610 million. The deal is expected to close in the fourth quarter of 2022. Stock up.
BioMarin (BMRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Milestone's (MIST) Tachycardia Study Data Fail to Impress Investors

10:30pm, Tuesday, 18'th Oct 2022 Zacks Investment Research
Milestone (MIST) reports positive top-line results from its late-stage study evaluating its lead candidate, etripamil, in patients with paroxysmal supraventricular tachycardia. The results fail to imp

Factors Setting the Tone for HCA Healthcare (HCA) Q3 Earnings

05:40pm, Tuesday, 18'th Oct 2022 Zacks Investment Research
HCA Healthcare's (HCA) third-quarter results are expected to reflect better emergency room visits and outpatient surgeries, partly offset by the continued incidence of labor costs.

Here's Why You Should Add Intra-Cellular Therapeutics (ITCI) Stock Now

02:43pm, Monday, 17'th Oct 2022 Zacks Investment Research
Intra-Cellular's (ITCI) product revenues are primarily driven by higher sales of its schizophrenia and bipolar disorder drug Caplyta. Caplyta is also being evaluated for other CNS indications.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE